-
1دورية أكاديمية
المؤلفون: Klug, E1 (AUTHOR), Rayner, B2 (AUTHOR), Wasserfall, M3 (AUTHOR), Kok, A4 (AUTHOR), Mpe, M5 (AUTHOR), Ruder, S6 (AUTHOR), Mohamed, NA7 (AUTHOR), Webb, D8 (AUTHOR) dawebb@mweb.co.za
المصدر: Journal of Endocrinology, Metabolism & Diabetes of South Africa. Apr2024, Vol. 29 Issue 1, p8-17. 10p.
مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *SODIUM-glucose cotransporters, *CHRONIC kidney failure, *TYPE 2 diabetes, *CARDIOVASCULAR diseases, *HEART failure patients
-
2دورية أكاديمية
المؤلفون: Gunawan, Pricilla Yani1 (AUTHOR) pricilla.yani@outlook.com, Gunawan, Paskalis Andrew2 (AUTHOR), Hariyanto, Timotius Ivan3 (AUTHOR)
المصدر: Diabetes Therapy. Mar2024, Vol. 15 Issue 3, p663-675. 13p.
مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *DEMENTIA patients, *DISEASE risk factors, *PEOPLE with diabetes, *GLUCOSE transporters, *SODIUM-glucose cotransporters, *CARDIOVASCULAR diseases
مصطلحات جغرافية: EUROPE
-
3دورية أكاديمية
المؤلفون: Horii, Takeshi1,2 (AUTHOR) t-horii@musashino-u.ac.jp, Oikawa, Yoichi2 (AUTHOR), Shimada, Akira2 (AUTHOR), Mihara, Kiyoshi1 (AUTHOR)
المصدر: Journal of Diabetes Investigation. Nov2023, Vol. 14 Issue 11, p1262-1267. 6p.
مصطلحات موضوعية: *SODIUM-glucose cotransporters, *SODIUM-glucose cotransporter 2 inhibitors, *CANAGLIFLOZIN, *TYPE 2 diabetes, *CARDIOVASCULAR diseases risk factors, *CARDIOVASCULAR diseases, *METFORMIN
مصطلحات جغرافية: JAPAN
-
4دورية أكاديمية
المؤلفون: YuJun Cai, HaiTao Zou, Rong Hu, Hao Chen, GuoHuan Yang, LiDan Gong
المصدر: Frontiers in Endocrinology; 2024, p1-5, 5p
مصطلحات موضوعية: RESPIRATORY diseases, NUTRITION disorders, SODIUM-glucose cotransporter 2 inhibitors, CARDIOVASCULAR diseases, GENETIC disorders, KIDNEYS, BREAST, DIABETIC acidosis
-
5دورية أكاديمية
المؤلفون: Simms-Williams, Nikita, Treves, Nir, Yin, Hui, Lu, Sally, Yu, Oriana, Pradhan, Richeek, Renoux, Christel, Suissa, Samy, Azoulay, Laurent
المصدر: BMJ: British Medical Journal; 5/4/2024, Vol. 385 Issue 8427, p1-13, 13p
مصطلحات موضوعية: CARDIOVASCULAR disease related mortality, COMBINATION drug therapy, GLUCAGON-like peptide-1 agonists, PEOPLE with diabetes, CARDIOVASCULAR diseases, RESEARCH funding, MAJOR adverse cardiovascular events, CARDIOVASCULAR diseases risk factors, HEART failure, LONGITUDINAL method, SODIUM-glucose cotransporter 2 inhibitors, TYPE 2 diabetes, COMPARATIVE studies, CONFIDENCE intervals, PSYCHOSOCIAL factors, KIDNEYS, PROPORTIONAL hazards models
-
6دورية أكاديمية
المؤلفون: Wong, Hon Jen, Lin, Norman H., Teo, Yao Neng, Syn, Nicholas L., Teo, Yao Hao, Sia, Ching-Hui
المصدر: American Journal of Cardiovascular Drugs; May2024, Vol. 24 Issue 3, p371-383, 13p
مصطلحات موضوعية: CARDIOVASCULAR disease related mortality, MORTALITY risk factors, METFORMIN, MEDICAL information storage & retrieval systems, CARDIOVASCULAR diseases, PLACEBOS, MAJOR adverse cardiovascular events, HOSPITAL care, LIFE expectancy, META-analysis, HEART failure, SYSTEMATIC reviews, MEDLINE, ODDS ratio, KAPLAN-Meier estimator, SODIUM-glucose cotransporter 2 inhibitors, TYPE 2 diabetes, MEDICAL databases, HEALTH outcome assessment, ONLINE information services, PROGRESSION-free survival, CONFIDENCE intervals, EVALUATION
-
7دورية أكاديمية
المؤلفون: Donna Shu-Han Lin1,2, An-Li Yu2, Hao-Yun Lo2,3, Cheng-Wei Lien2,3, Jen-Kuang Lee2,4,5,6,7 b85401104@gmail.com, Fu-Tien Chiang4,8, Yu-Kang Tu9,10,11 yukangtu@ntu.edu.tw
المصدر: European Journal of Endocrinology. Jul2023, Vol. 189 Issue 1, pS17-S25. 9p.
مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *CARDIOVASCULAR diseases, *RANDOMIZED controlled trials
-
8دورية أكاديمية
المؤلفون: Bagheri, Bahador1,2 (AUTHOR), Yaribeygi, Habib3 (AUTHOR), Taherifard, Erfan4 (AUTHOR), Talasaz, Azita Hajhossein5 (AUTHOR), Bagheri, Haleh6 (AUTHOR), Darban, Mahboubeh7 (AUTHOR), Tabrizi, Reza8,9,10 (AUTHOR), Najafi, Siamak11 (AUTHOR), Khodadost, Mahmoud12 (AUTHOR) mahmodkhodadost@yahoo.com, Akbari, Maryam13 (AUTHOR) ma_akbari@sums.ac.ir
المصدر: Fundamental & Clinical Pharmacology. Jun2023, Vol. 37 Issue 3, p481-492. 12p.
مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *SODIUM-glucose cotransporters, *TYPE 2 diabetes, *CHRONIC kidney failure, *CARDIOVASCULAR diseases, *ORAL medication
-
9دورية أكاديمية
المؤلفون: d'Aiello, Alessia1,2 (AUTHOR) alessia.daiello@guest.policlinicogemelli.it, Bonanni, Alice1 (AUTHOR), Vinci, Ramona1,2 (AUTHOR), Pedicino, Daniela1 (AUTHOR) daniela.pedicino@policlinicogemelli.it, Severino, Anna1,2 (AUTHOR), De Vita, Antonio1,2 (AUTHOR), Filomia, Simone2 (AUTHOR), Brecciaroli, Mattia2 (AUTHOR), Liuzzo, Giovanna1,2 (AUTHOR)
المصدر: International Journal of Molecular Sciences. May2023, Vol. 24 Issue 10, p8643. 19p.
مصطلحات موضوعية: *EXENATIDE, *SODIUM-glucose cotransporter 2 inhibitors, *EMPAGLIFLOZIN, *TYPE 2 diabetes, *CARDIOVASCULAR diseases risk factors, *GLUCAGON-like peptide 1, *MAJOR adverse cardiovascular events
-
10دورية أكاديمية
المؤلفون: Zmaili, Mohammad, Alzubi, Jafar, Alkhayyat, Motasem, Albakri, Almaza, Alkhalaileh, Feras, Longinow, Joshua, Moudgil, Rohit
المصدر: Cancers; Apr2024, Vol. 16 Issue 8, p1450, 23p
مصطلحات موضوعية: TUMOR risk factors, CARDIOVASCULAR disease prevention, TUMOR prevention, CARDIOVASCULAR diseases, EXERCISE, ASPIRIN, ACE inhibitors, CARDIO-oncology, CARDIOVASCULAR diseases risk factors, CANCER patients, CALCIUM antagonists, ANGIOTENSIN receptors, ADRENERGIC beta blockers, STATINS (Cardiovascular agents), SODIUM-glucose cotransporter 2 inhibitors, TUMORS, INFLAMMATION, MEDICAL screening